| Year | Title | Author(s) |
|---|
| 2015 |
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Journal Of Experimental Medicine |
Flierl, U Nero, TL Lim, B Arthur, JF Yao, Y Jung, SM Gitz, E Pollitt, AY Zaldivia, MTK Jandrot-Perrus, M Schafer, A Nieswandt, B Andrews, RK Parker, MW Gardiner, EE Peter, K |
| 2018 |
Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment
J. Thromb. Haemost. |
Flierl, U Nero, TL Lim, B Andrews, RK Parker, MW Gardiner, EE Peter, K |
| 2022 |
Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice
Jci Insight |
Popp, SK Vecchio, F Brown, DJ Fukuda, R Suzuki, Y Takeda, Y Wakamatsu, R Sarma, MA Garrett, J Giovenzana, A Bosi, E Lafferty, ARA Brown, KJ Gardiner, EE Coupland, LA Thomas, HE Chong, BH Parish, CR Battaglia, M Petrelli, A Simeonovic, CJ |